Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Peschiera del Garda
Clinical trial register · Italy

Clinical Trials in Peschiera del Garda, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Casa di Cura Dott. Pederzoli12 AstraZeneca7 Amgen2 Bristol-Myers Squibb2 Merck Sharp & Dohme LLC2
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in Peschiera del Garda

35 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
NUT Project: Nutritional Support in Thoracic Oncology
NCT07817329Oncologic Diseases, Lung Cancer (NSCLC)
Casa di Cura Dott. Pederzoli
Observational
100
Peschiera del Garda
2026-10
Recruiting
Casa di Cura Dott. Pederzoli
Observational
200
Peschiera del Garda
2026-10
Recruiting
Pfizer
Phase 2
120
Peschiera del Garda
2026-06-30
Recruiting
Casa di Cura Dott. Pederzoli
Observational
1,000
Peschiera del Garda
2026-04
Recruiting
Casa di Cura Dott. Pederzoli
Observational
200
Bologna, Padova, Roma, Trieste, Udine, Peschiera del Garda
2026-04
Not yet open
PAN-CLO-BU (PANcreas-CLOstridium-BUtyricum)
NCT07422103Pancreatic Cancer, Pancreatic Diseases, Gastrointestinal Symptoms, Clostridium Butyricum Miyairi
Casa di Cura Dott. Pederzoli
Not applicable
158
Peschiera del Garda
2026-03-15
Recruiting
Casa di Cura Dott. Pederzoli
Not applicable
15
Peschiera del Garda
2026-03
Recruiting
Casa di Cura Dott. Pederzoli
Not applicable
185
Pavia, Peschiera del Garda
2026-02-26
Recruiting
Casa di Cura Dott. Pederzoli
Observational
64
Naples, Abano Terme, Udine, Peschiera del Garda
2026-02-17
Recruiting
Amgen
Phase 3
750
Foggia, Milan, Modena, Orbassano, Peschiera del Garda, Rozzano, Trento
2025-11-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
Naples, Rome, Milan, Rozzano, Orbassano, Florence, Castelfranco Veneto, Peschiera del Garda
2025-11-26
Recruiting
Casa di Cura Dott. Pederzoli
Not applicable
50
Peschiera del Garda
2025-09-02
Recruiting
Casa di Cura Dott. Pederzoli
Observational
500
Peschiera del Garda
2025-05-22
Recruiting
AstraZeneca
Phase 3
830
Candiolo, Lecco, Lucca, Meldola, Milan, Naples, Peschiera del Garda, Pisa
2025-04-10
Recruiting
Gilead Sciences
Phase 3
695
Aviano, Candiolo, Lucca, Milan, Naples, Pesaro, Peschiera del Garda, Roma
2025-04-04
Recruiting
Summit Therapeutics
Phase 3
780
Rome, Bari, Bergamo, Milan, Orbassano, Parma, Peschiera del Garda
2025-02-27
Recruiting
Bristol-Myers Squibb
Phase 3
530
Naples, Milan, Rome, Perugia, Peschiera del Garda, Bologna
2025-02-25
Recruiting
Casa di Cura Dott. Pederzoli
Observational
4,000
Peschiera del Garda
2025-02-23
Recruiting
BioNTech SE
Phase 3
621
Avellino, Aviano, Cremona, Lucca, Meldola, Monza, Naples, Peschiera del Garda
2025-02-03
Recruiting
AstraZeneca
Phase 3
1,160
Florence, Legnano, Livorno, Monza, Peschiera del Garda, Rome
2024-11-27
Recruiting
AstraZeneca
Phase 3
1,160
Florence, Legnano, Livorno, Monza, Orbassano, Padova, Peschiera del Garda, Roma
2024-11-18
Recruiting
Casa di Cura Dott. Pederzoli
Not applicable
40
Peschiera del Garda
2024-11-07
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Bari, Ravenna, Monza, Milan, Naples, Rome, Peschiera del Garda, Bergamo
2024-10-07
Recruiting
Exercise Activity to Improve Mobility in Patients With CKD and PAD
NCT06621264Chronic Kidney Disease Stage 3 and 4, Peripheral Artery Disease (PAD)
University Hospital of Ferrara
Not applicable
124
Ferrara, Peschiera del Garda, Reggio Calabria
2024-10-01
Active, closed
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
NCT06430866Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
DrugsABP 234·Pembrolizumab
Amgen
Phase 3
163
Cona, Cuneo, Florence, Lucca, Monserrato, Naples, Peschiera del Garda, Ravenna
2024-09-12
Active, closed
AstraZeneca
Phase 2
142
Bari, Bologna, Milan, Naples, Palermo, Pavia, Peschiera del Garda
2024-02-22
Active, closed
St. Antonius Hospital
Not applicable
493
Peschiera del Garda
2023-06-08
Active, closed
AstraZeneca
Phase 2
188
Avellino, Brescia, Lecce, Milan, Naples, Palermo, Peschiera del Garda, Reggio Emilia
2023-03-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
614
Rome, Bergamo, Milan, Naples, Florence, Peschiera del Garda, Parma
2023-02-06
Active, closed
AstraZeneca
Phase 3
1,350
Florence, Lecco, Messina, Naples, Orbassano, Padova, Parma, Peschiera del Garda
2022-12-29
Recruiting
SELUTION4BTK Trial
NCT05055297Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
M.A. Med Alliance S.A.
Not applicable
376
Peschiera del Garda, Cotignola, Genova
2022-05-19
Active, closed
CStone Pharmaceuticals
Phase 3
534
Feltre, Padova, Peschiera del Garda, Cremona, Pavia
2019-12-13
Recruiting
Registry of Subjects at Risk of Pancreatic Cancer
NCT04095195Familial Pancreatic Cancer, BRCA1 Mutation, BRCA2 Mutation, Lynch Syndrome
Associazione Italiana per lo Studio del Pancreas
Observational
1,000
Rozzano, Peschiera del Garda, Milan, Verona
2019-08-20
Recruiting
Protocol ITANET - Registry
NCT04282083Gastro-entero Pancreatic Neuroendocrine Tumors
Italian Association Neuroendocrine Tumors
Observational
3,600
Rozzano, Peschiera del Garda, Ancona, Bari, Bologna, Bolzano, Brescia, Brindisi
2019-05-25
Active, closed
AstraZeneca
Phase 2
367
Avellino, Florence, Milan, Orbassano, Padova, Parma, Perugia, Peschiera del Garda
2019-01-09
Rows per page Showing 1–35 of 35
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-italy/city/peschiera-del-garda

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 35 of those studies with a site in Peschiera del Garda.

How many clinical trials are recruiting in Peschiera del Garda?

26 of the 35 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Peschiera del Garda), 35 studies
PhaseStudiesRecruitingShare
Phase 3141040%
Observational9925.7%
Not applicable8622.9%
Phase 24111.4%

Most active sponsors

Lead sponsors with the most studies (Peschiera del Garda)
Lead sponsorStudiesRecruiting
Casa di Cura Dott. Pederzoli1211
AstraZeneca73
Amgen21
Bristol-Myers Squibb22
Merck Sharp & Dohme LLC21
Associazione Italiana per lo Studio del Pancreas11
BioNTech SE11
CStone Pharmaceuticals10
Gilead Sciences11
Italian Association Neuroendocrine Tumors11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.